Bb Biotech as of March 31, 2015
Portfolio Holdings for Bb Biotech
Bb Biotech holds 27 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 12.2 | $410M | 3.6M | 115.28 | |
| ISIS Pharmaceuticals | 10.9 | $365M | 5.7M | 63.67 | |
| Incyte Corporation (INCY) | 10.3 | $348M | 3.8M | 91.66 | |
| Gilead Sciences (GILD) | 8.4 | $281M | 2.9M | 98.13 | |
| Agios Pharmaceuticals (AGIO) | 5.2 | $174M | 1.8M | 94.30 | |
| Medivation | 4.9 | $165M | 1.3M | 129.07 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.7 | $157M | 1.3M | 117.97 | |
| Radius Health | 4.6 | $153M | 3.7M | 41.16 | |
| Neurocrine Biosciences (NBIX) | 3.8 | $127M | 3.2M | 39.71 | |
| Puma Biotechnology (PBYI) | 3.7 | $123M | 522k | 236.11 | |
| Alexion Pharmaceuticals | 3.5 | $117M | 672k | 173.30 | |
| Receptos | 3.1 | $105M | 635k | 164.89 | |
| Synageva Biopharma | 3.0 | $100M | 1.0M | 97.53 | |
| Halozyme Therapeutics (HALO) | 2.7 | $92M | 6.4M | 14.28 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $89M | 198k | 451.48 | |
| Alnylam Pharmaceuticals (ALNY) | 2.6 | $87M | 836k | 104.42 | |
| Ptc Therapeutics I (PTCT) | 2.1 | $72M | 1.2M | 60.85 | |
| Novavax | 2.1 | $70M | 8.5M | 8.27 | |
| Tetraphase Pharmaceuticals | 1.6 | $54M | 1.5M | 36.64 | |
| Tesaro | 1.5 | $49M | 855k | 57.40 | |
| Clovis Oncology | 1.4 | $46M | 618k | 74.23 | |
| Intercept Pharmaceuticals In | 1.3 | $44M | 155k | 282.02 | |
| Cempra | 1.2 | $42M | 1.2M | 34.31 | |
| Infinity Pharmaceuticals (INFIQ) | 1.1 | $37M | 2.6M | 13.98 | |
| ImmunoGen | 0.8 | $25M | 2.8M | 8.95 | |
| Theravance | 0.4 | $13M | 832k | 15.72 | |
| Achillion Pharmaceuticals | 0.4 | $13M | 1.3M | 9.86 |
